[Effect of estramustine phosphate on hormone refractory prostate cancer].

Author: HamanoS, IgarashiT, MurakamiS, ShimazakiJ, ShiomiK, SuzukiN, TanakaM

Paper Details 
Original Abstract of the Article :
Clinical effects of estramustine phosphate (EMT) on hormone refractory prostate cancer were studied. Prostate cancer relapsed in 70 of the 259 patients with stage C and D diseases who had initially responded to endocrine therapy. After cancer relapse, endocrine therapy was changed to oral administra...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/9127765

データ提供:米国国立医学図書館(NLM)

Estramustine Phosphate: A New Weapon in the Fight Against Prostate Cancer

Prostate cancer is a serious health challenge, much like a formidable sandstorm that can threaten the health of the body. This study explores the efficacy of estramustine phosphate (EMT) in treating hormone-refractory prostate cancer, a condition that often proves difficult to manage. The authors investigated the effects of EMT on patients with advanced prostate cancer who had stopped responding to traditional hormone therapy. Their findings suggest that EMT may offer a promising treatment option for these patients, providing a much-needed oasis in the desert of prostate cancer care.

A Promising Treatment for Advanced Prostate Cancer

The study found that EMT therapy led to partial responses or stable disease in a significant proportion of patients with hormone-refractory prostate cancer. It also showed that EMT-treated patients experienced a longer survival compared to those who continued on traditional hormone therapy alone. These findings suggest that EMT could be a valuable treatment option for patients with advanced prostate cancer, providing a new avenue for managing this challenging condition. It's like discovering a hidden oasis in the desert of prostate cancer treatment, offering a new source of hope and relief.

Finding a Path to Relief

This research sheds light on the potential of EMT as a treatment option for hormone-refractory prostate cancer. It provides valuable information for healthcare providers, offering a new tool for managing this challenging disease. It's like finding a new compass to guide us through the desert of prostate cancer treatment, one that could lead to better outcomes for patients.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the fight against prostate cancer, providing evidence for the effectiveness of EMT in treating hormone-refractory disease. It's a reminder that even in the most challenging medical landscapes, there is always the possibility of finding a new oasis, a new treatment that can provide relief and improve outcomes for patients.

Date :
  1. Date Completed 1997-06-13
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

9127765

DOI: Digital Object Identifier

9127765

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.